Green Lifescience Co., Ltd.

KOSDAQ:A114450 Voorraadrapport

Marktkapitalisatie: ₩41.9b

Green Lifescience Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Green Lifescience's earnings have been declining at an average annual rate of -65.1%, while the Life Sciences industry saw earnings growing at 31.2% annually. Revenues have been declining at an average rate of 5.3% per year.

Belangrijke informatie

-65.1%

Groei van de winst

-64.5%

Groei van de winst per aandeel

Life Sciences Groei van de industrie53.7%
Inkomstengroei-5.3%
Rendement op eigen vermogen-32.8%
Nettomarge-48.9%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Geen updates

Recent updates

Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 36% Dip In Price Shows Sentiment Is Matching Revenues

Sep 13
Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 36% Dip In Price Shows Sentiment Is Matching Revenues

The Market Doesn't Like What It Sees From Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Revenues Yet

Jul 30
The Market Doesn't Like What It Sees From Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Revenues Yet

Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?

Mar 26
Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?

KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?

Feb 22
KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?

Investors Who Bought KPX Lifescience.Co.Ltd (KOSDAQ:114450) Shares Three Years Ago Are Now Up 180%

Dec 31
Investors Who Bought KPX Lifescience.Co.Ltd (KOSDAQ:114450) Shares Three Years Ago Are Now Up 180%

Opbrengsten en kosten

Hoe Green Lifescience geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

KOSDAQ:A114450 Opbrengsten, kosten en inkomsten (KRW Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2424,604-12,0401,994303
31 Mar 2424,993-14,4162,205221
31 Dec 2322,369-16,3582,046112
30 Sep 2323,129-5,1771,918114
30 Jun 2322,314-5,0581,965201
31 Mar 2325,900-4,5131,569427
31 Dec 2236,505-3,5261,992426
30 Sep 2239,978-2,2672,136461
30 Jun 2239,758-2,6962,210348
31 Mar 2234,441-2,5242,361110
31 Dec 2125,338-3,1362,102110
30 Sep 2122,361-2,6151,7340
30 Jun 2121,203-1,9281,7550
31 Mar 2124,440-8541,7060
31 Dec 2024,561-1,0591,6990
30 Sep 2028,036-81,9530
30 Jun 2031,8754281,8340
31 Mar 2033,6571401,9190
31 Dec 1937,6181,1962,2040
30 Sep 1934,305-6012,0950
30 Jun 1934,030-8152,1670
31 Mar 1931,294-1,5512,1810
31 Dec 1832,754-1,4451,9960
30 Sep 1836,947-6072,1190
30 Jun 1839,9784332,2300
31 Mar 1842,1159532,3170
31 Dec 1742,5852,2252,2090
30 Sep 1741,6654,0812,1100
30 Jun 1743,5154,4082,0530
31 Mar 1746,1175,2392,2370
31 Dec 1643,3044,5042,3070
30 Sep 1646,7405,8822,3410
30 Jun 1646,1535,6672,4510
31 Mar 1646,2195,6612,2340
31 Dec 1545,5085,3872,2110
30 Sep 1543,5932,2622,0910
30 Jun 1542,1411,0751,9410
31 Mar 1535,198-2431,8800
31 Dec 1437,081-1,0622,0430
30 Sep 1436,940-1,6231,8390
30 Jun 1432,982-2,1761,9130
31 Mar 1434,966-1,6141,9650
31 Dec 1334,526-1,3122,0650

Kwaliteitswinsten: A114450 is currently unprofitable.

Groeiende winstmarge: A114450 is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: A114450 is unprofitable, and losses have increased over the past 5 years at a rate of 65.1% per year.

Versnelling van de groei: Unable to compare A114450's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: A114450 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (18%).


Rendement op eigen vermogen

Hoge ROE: A114450 has a negative Return on Equity (-32.8%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden